MedPath
HSA Approval

SODIUM CHLORIDE INTRAVENOUS INFUSION BP 0.9%

SIN05951P

SODIUM CHLORIDE INTRAVENOUS INFUSION BP 0.9%

SODIUM CHLORIDE INTRAVENOUS INFUSION BP 0.9%

May 18, 1991

B. BRAUN SINGAPORE PTE LTD

B. BRAUN SINGAPORE PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantB. BRAUN SINGAPORE PTE LTD
Licence HolderB. BRAUN SINGAPORE PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

B05XA03

sodium chloride

Manufacturer Information

B. Braun Singapore Pte Ltd.

B BRAUN MEDICAL INDUSTRIES SDN BHD

B BRAUN MELSUNGEN AG

B.Braun Medical S.A.

B. Braun Melsungen AG (LIFE plant)

PT. B.BRAUN PHARMACEUTICAL INDONESIA

Active Ingredients

SODIUM CHLORIDE

0.9 g/100 ml

Sodium chloride

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.